Total Payments
$7,044
2024 Payments
$2,231
Companies
30
Transactions
405
Medicare Patients
297
Medicare Billing
$31,868
Payment Breakdown by Category
Food & Beverage$7,044 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,044 | 405 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,897 | 119 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $959.89 | 68 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $944.14 | 75 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $494.72 | 5 | $0 (2023) |
| INTERCEPT PHARMACEUTICALS, INC. | $325.31 | 17 | $0 (2023) |
| Janssen Biotech, Inc. | $303.15 | 17 | $0 (2024) |
| Celgene Corporation | $208.24 | 17 | $0 (2024) |
| GENZYME CORPORATION | $183.13 | 10 | $0 (2024) |
| QOL Medical, LLC | $182.84 | 7 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $167.45 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,231 | 143 | ABBVIE INC. ($780.68) |
| 2023 | $2,590 | 144 | ABBVIE INC. ($716.61) |
| 2022 | $2,081 | 116 | ABBVIE INC. ($381.74) |
| 2021 | $142.35 | 2 | Janssen Pharmaceuticals, Inc ($124.59) |
All Payment Transactions
405 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Gastroenterology | ||||||
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/10/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $34.77 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: VIROLOGY | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 169 | 283 | $50,626 | $20,433 |
| 2022 | 2 | 100 | 153 | $26,253 | $11,361 |
| 2021 | 1 | 14 | 16 | $240.00 | $36.00 |
| 2020 | 1 | 14 | 17 | $255.00 | $38.00 |
Total Patients
297
Total Services
469
Medicare Billing
$31,868
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 232 | $42,016 | $17,113 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 32 | $4,115 | $1,725 | 41.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $4,495 | $1,595 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 138 | $24,453 | $10,614 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 15 | $1,800 | $747.32 | 41.5% |
| 81003 | Automated urinalysis test | Office | 2021 | 14 | 16 | $240.00 | $36.00 | 15.0% |
| 81003 | Automated urinalysis test | Office | 2020 | 14 | 17 | $255.00 | $38.00 | 14.9% |
About Donald Ward
Donald Ward is a Family healthcare provider based in Maryville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2019. The National Provider Identifier (NPI) number assigned to this provider is 1154979359.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Donald Ward has received a total of $7,044 in payments from pharmaceutical and medical device companies, with $2,231 received in 2024. These payments were reported across 405 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($7,044).
As a Medicare-enrolled provider, Ward has provided services to 297 Medicare beneficiaries, totaling 469 services with total Medicare billing of $31,868. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Maryville, TN
- Active Since 08/30/2019
- Last Updated 11/03/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1154979359
Products in Payments
- ENTYVIO (Biological) $811.37
- XIFAXAN (Drug) $684.07
- RINVOQ (Biological) $592.92
- STELARA (Biological) $534.62
- SKYRIZI (Biological) $447.75
- LINZESS (Drug) $417.57
- OCALIVA (Drug) $325.31
- DUPIXENT (Biological) $299.65
- TRULANCE (Drug) $260.07
- MAVYRET (Drug) $250.10
- ZENPEP (Drug) $234.24
- REMICADE (Biological) $213.43
- ZEPOSIA (Drug) $192.56
- VOQUEZNA (Drug) $162.70
- GIMOTI (Drug) $129.57
- XARELTO (Drug) $124.59
- MONOFERRIC (Drug) $119.52
- SUCRAID (Drug) $114.38
- CREON (Drug) $98.58
- REBYOTA (Biological) $88.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Maryville
Jaime Mendoza, Pmhnp, PMHNP
Family — Payments: $69,449
Family $69,449
Jessica Garcia, Np-C, NP-C
Family — Payments: $20,515
Family $20,515
Heather Thompson, Aprn, APRN
Family — Payments: $10,772
Family $10,772
Mrs. Sheena Eslinger, Fnp-Bc, FNP-BC
Family — Payments: $9,815
Family $9,815
Mr. Heath Long, Fnp-C, FNP-C
Family — Payments: $8,887
Family $8,887
Tonya Bosaw, Np, NP
Family — Payments: $7,640
Family $7,640